N-linoleyltyrosine resisted the growth of non-small cell lung cancer cells via the regulation of CB1 and CB2 involvement of PI3K and ERK pathways
Background: N-linoleyltyrosine (NITyr), one of the anandamide analogs, exerts activity via the endocannabinoid receptors (CB1 and CB2), which showed anti-tumor effects in various tumors. Therefore, we speculated that NITyr might show anti-non-small cell lung cancer (NSCLC) effects via the CB1 or CB2...
Saved in:
Main Authors: | Yan Hu (Author), Zhe Zhao (Author), Yuan-Ting Liu (Author), Ze-Cheng Xu (Author), Jing-Yi Li (Author), Zheng-Yu Yang (Author), Rui-Wang (Author), Yun-Qi Yang (Author), Jia-Hui Zhang (Author), Si-Yuan Qiu (Author), Tao He (Author), Yi-Ying Wu (Author), Sha Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
N-Stearoyl-L-Tyrosine Inhibits the Senescence of Neural Stem/Progenitor Cells Induced by Aβ1-42 via the CB2 Receptor
by: Wen-Qing Li, et al.
Published: (2016) -
Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes
by: Gemma Navarro, et al.
Published: (2018) -
N-linoleyltyrosine exerts neuroprotective effects in APP/PS1 transgenic mice via cannabinoid receptor-mediated autophagy
by: Chun-mei Long, et al.
Published: (2021) -
β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms
by: Xiang-Hu He, et al.
Published: (2021) -
The Impact of CB1 Receptor on Inflammation in Skeletal Muscle Cells
by: Haddad M
Published: (2021)